Health
Gene therapy to the inner retina prevents blindness in mouse model of CLN3 Batten disease – News-Medical.Net
Gene therapy to the inner retina prevented blindness in a mouse model of the neuro-degenerative disorder CLN3 Batten disease.
Reviewed by Emily Henderson, B.Sc.Aug 10 2020
Gene therapy to the inner retina prevented blindness in a mouse model of the neuro-degenerative disorder CLN3 Batten disease. Adeno-associated viral (AAV)-mediated expression of the human CLN3 gene led to significant survival of bipolar cells and pre-served retinal function, as reported in the peer-reviewed journal Human Gene Therapy.
Batten disease is a group of fatal, inherited lysosomal storage disorders that predominantly affect children. The m…
-
General23 hours ago“Accumulation of defects”. A-G report scathing on Navy shipbuilding
-
General22 hours agoG7 agrees to avoid higher taxes for US, UK companies
-
Noosa News21 hours agoFood supply chain system costs farmers and regions millions of dollars
-
Business21 hours agoBuy and hold NDQ and these ASX ETFs for 10 years